Your browser is no longer supported. Please, upgrade your browser.
AUPH Aurinia Pharmaceuticals Inc. daily Stock Chart
Aurinia Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.72 Insider Own- Shs Outstand82.10M Perf Week-2.53%
Market Cap537.76M Forward P/E- EPS next Y-0.55 Insider Trans- Shs Float44.84M Perf Month0.77%
Income- PEG- EPS next Q-0.12 Inst Own- Short Float24.25% Perf Quarter-7.88%
Sales0.15M P/S3658.24 EPS this Y-12.10% Inst Trans- Short Ratio4.41 Perf Half Y158.89%
Book/sh2.10 P/B3.11 EPS next Y25.70% ROA- Target Price11.30 Perf Year116.17%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.74 - 10.54 Perf YTD211.90%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-38.24% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low274.68% ATR0.35
Employees12 Current Ratio- Sales Q/Q-45.60% Oper. Margin- RSI (14)49.11 Volatility7.18% 4.86%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.77 Prev Close6.55
ShortableYes LT Debt/Eq- EarningsAug 14 AMC Payout- Avg Volume2.47M Price6.51
Recom1.60 SMA200.88% SMA50-0.13% SMA20030.43% Volume1,895,434 Change-0.61%
May-18-17Reiterated H.C. Wainwright Buy $12 → $10
Apr-11-17Initiated Cantor Fitzgerald Overweight $14
Mar-22-17Reiterated FBR & Co. Outperform $9 → $11
Dec-30-16Reiterated H.C. Wainwright Buy $10 → $8
Aug-17-16Reiterated H.C. Wainwright Buy $7 → $10
Jun-30-16Initiated H.C. Wainwright Buy $7
May-08-15Initiated MLV & Co Buy $9
Jul-21-17 02:42PM  3 Been-There-Done-That Biotech CEOs Who Are Doing it Again Motley Fool
Jul-20-17 09:02PM  3 Hottest Biotech Stocks of 2017 -- Are They Still Buys Now? Motley Fool
Jul-18-17 08:10AM  Today's Research Reports on Stocks to Watch: Soligenix and Aurinia Pharmaceuticals Accesswire -8.99%
Jul-17-17 07:00PM  Cramer Remix: Why its still worth owning Procter & Gamble CNBC +10.86%
09:01AM  Aurinia Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AUPH-US : July 17, 2017 Capital Cube
07:00AM  3 Small Biotech Stocks Being Run by Proven Winners Motley Fool
Jul-14-17 08:00PM  Is Aurinia Pharmaceuticals' Management Its Best Asset? Motley Fool +5.16%
Jul-12-17 09:31PM  After Its Drop, Is Aurinia Pharmaceuticals Stock Now A Buy? Motley Fool
09:15PM  Aurinia Resolves Temporary Non-Compliance with Nasdaqs Audit Committee Composition Rule Business Wire
Jul-10-17 08:32AM  Options Traders Expect Huge Moves in Aurinia Pharmaceuticals (AUPH) Stock Zacks
Jun-22-17 04:30PM  Aurinia Announces Results of Annual General Meeting Business Wire
Jun-21-17 07:00AM  Aurinia to Host Annual General Meeting of Shareholders and Webcast on June 21 in Vancouver, BC Business Wire
Jun-20-17 08:53AM  Do Options Traders Know Something About Aurinia Pharmaceuticals (AUPH) Stock We Don't? Zacks +9.97%
Jun-17-17 08:01AM  New Data Suggests Aurinia Pharmaceuticals Is Onto Something Big Motley Fool
Jun-16-17 10:45AM  Aurinia Pharma Rises Following Updated Mid-Stage Results 24/7 Wall St.
07:58AM  Voclosporin Remission Data from the Phase IIb AURA-LV Study Highlighted at EULAR 2017 Business Wire
Jun-05-17 11:27AM  Aurinia Presents Additional Data from Phase IIB AURA-LV Study, Demonstrating Stable Renal Function and Blood Pressure without Electrolyte Complications Through 48 Weeks Business Wire
Jun-02-17 09:37AM  Aurinia Pharmaceuticals, Inc. :AUPH-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
May-30-17 04:19PM  Aurinia to Participate in Late Breaking Oral Presentations at Two Upcoming Scientific Conferences Business Wire -5.82%
May-17-17 04:02PM  Aurinia Doses First Patient in AURORA Phase 3 Clinical Trial of Voclosporin in Lupus Nephritis Business Wire
May-16-17 08:00AM  Today's Research Reports on Stocks to Watch: Aurinia Pharmaceuticals and Bellerophon Therapeutics Accesswire
May-15-17 08:47AM  Aurinia reports 1Q loss Associated Press -5.73%
08:00AM  Aurinia Reports First Quarter 2017 Financial Results, Announces Initiation of Phase III Aurora Clinical Trial, and Provides Operational Highlights Business Wire
May-11-17 06:12PM  Aurinia Pharmaceuticals, Inc. Value Analysis (NASDAQ:AUPH) : May 11, 2017 Capital Cube
May-09-17 09:00AM  Is a Surprise Coming for Aurinia Pharmaceuticals (AUPH) This Earnings Season? Zacks
08:25AM  Aurinia Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AUPH-US : May 9, 2017 Capital Cube
08:00AM  Pharma Industry Veteran Dr. George Milne Joins Aurinias Board of Directors Business Wire
May-01-17 02:32PM  3 Best Biotech Stocks During Trump's First 100 Days Motley Fool +5.28%
Apr-26-17 01:03PM  Aurinia to Present at Bloom Burton & Co. Healthcare Conference Business Wire +5.44%
Apr-21-17 07:30AM  Today's Research Reports on Stocks to Watch: Aurinia Pharmaceuticals and Immune Pharmaceuticals Accesswire
Apr-20-17 05:00PM  Aurinia Releases Additional 48-Week Data from the AURA-LV Study During Late-Breaking Session at the National Kidney Foundation 2017 Spring Clinical Meetings Business Wire
Apr-19-17 11:10AM  This Trading-Range Action Is Not Offering Much
08:32AM  Implied Volatility Surging for Aurinia Pharmaceuticals(AUPH) Stock Options Zacks
Apr-17-17 04:02PM  Aurinia Completes Licensing Deal with Merck Animal Health for Its Nanomicellar Formulation of Voclosporin for the Treatment of Canine Dry Eye Syndrome Business Wire
Apr-10-17 01:30PM  Aurinia to Host Investor Event and Webcast on April 20th in Orlando, FL Business Wire
Apr-07-17 05:41PM  Aurinia Pharmaceuticals Plans to Take a Big Step Forward Motley Fool +6.98%
01:35PM  Here's Why Aurinia Pharmaceuticals Rose as Much as 10.8% This Morning Motley Fool
10:55AM  Aurinia Pharmaceuticals Jumps on Phase 3 Planned Trial 24/7 Wall St.
10:23AM  Aurinia Plans Phase 3 Study for Lupus Drug Investopedia
Apr-06-17 05:12PM  Aurinia Announces Development Plans for Voclosporin in Europe and Japan Business Wire
Apr-05-17 09:27AM  Q1 Roundup: Winners and Losers of Biotech Sector Investopedia
09:27AM  Q1 Roundup: Winners and Losers of Biotech Sector
Apr-04-17 09:15AM  BC Tech Fund to Invest in Lumira Capital IV, L.P. CNW Group
09:15AM  BC Tech Fund to Invest in Lumira Capital IV, L.P.
Mar-31-17 07:29PM  Aurinia Pharmaceuticals: Where to From Here? Motley Fool
07:29PM  Aurinia Pharmaceuticals: Where to From Here? at Motley Fool
Mar-27-17 11:05AM  Aurinia's Voclosporin Reports Positive Results Investopedia
11:05AM  Aurinia's Voclosporin Reports Positive Results at Investopedia
03:30AM  Aurinia Highlights 48-Week Data from Open-Label AURION Study at 12th International Congress on SLE (LUPUS 2017) & the 7th Asian Congress on Autoimmunity (ACA 2017) Business Wire
Mar-24-17 12:00PM  3 Hot Biotech Stocks Now Motley Fool
12:00PM  3 Hot Biotech Stocks Now at Motley Fool
Mar-22-17 08:47AM  Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock? Zacks
08:47AM  Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock?
Mar-21-17 10:39AM  Traders Are Aggressively Fading the Open
09:30AM  Financials of Aurinia Pharmaceuticals and Catalyst Pharmaceuticals are Getting Stability Accesswire
Mar-20-17 04:05PM  Aurinia Closes US$173.1 Million Public Offering of Common Shares and Full Exercise of Underwriters Option to Purchase Additional Common Shares Business Wire +14.03%
11:25AM  Biotechs Remain the Best Place For Stock Picking
09:06AM  Aurinia Pharmaceuticals, Inc. :AUPH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
Mar-17-17 12:11PM  Shark Bites: Market Keeps Giving Back Gains
Mar-16-17 04:20PM  Why Aurinia Pharmaceuticals Shares Are on a Wild Ride Lately at Motley Fool
04:01PM  Aurinia Announces Presentation at 12th International Congress on SLE (LUPUS 2017) & the 7th Asian Congress on Autoimmunity (ACA 2017) Business Wire
10:16AM  Aurinia Pharmaceuticals, Inc. :AUPH-US: Earnings Analysis: 2016 By the Numbers : March 16, 2017
Mar-15-17 01:56PM  Aurinia Pharmaceuticals Inc (AUPH) In A Common Shares Public Offering To Raise Over $150 Million at Insider Monkey
Mar-14-17 04:03PM  Aurinias stock plunges after big share offering at deep discount at MarketWatch -25.05%
11:09AM  Lantheus Holdings, Aurinia, Whiting, Oasis, and More: What is Going on With These Five Falling Stocks? at Insider Monkey
10:50AM  Here's Why Aurinia Pharmaceuticals Dropped 25.5% at the Opening at Motley Fool
09:01AM  Twitter Traders Yap, but Aurinia Raising $150 Million was a Well-Executed Deal
08:00AM  Aurinia Prices US$150.5 Million Public Offering of Common Shares Business Wire
Mar-13-17 05:14PM  Market Takes 'National Napping Day' Seriously +24.00%
05:03PM  Why Mobileye, Aurinia Pharmaceuticals, and Blackstone Group Jumped Today at Motley Fool
05:01PM  Aurinia Pharmaceuticals shares drop on secondary offering plan at MarketWatch
04:01PM  Aurinia Announces Public Offering of Common Shares Business Wire
Mar-10-17 03:39PM  Aurinia Offers Promising 2017 Forecast (AUPH) at Investopedia +9.25%
08:15AM  Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session
07:37AM  Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps
Mar-09-17 04:42PM  Here's Why Aurinia Pharmaceuticals Rose as Much as 15.6% Today at Motley Fool +8.66%
09:22AM  Aurinia reports 4Q loss
08:30AM  Aurinia Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Operational Highlights Business Wire
Mar-08-17 10:59AM  Answering The Important Aurinia Pharmaceuticals Inc (AUPH) Questions at Insider Monkey
09:30AM  Today's Research Reports on Trending Tickers: MeetMe and Aurinia Pharmaceuticals Accesswire
Mar-07-17 11:53AM  Here's Why Aurinia Pharmaceuticals Stock Is Soaring Today at Motley Fool +32.46%
10:38AM  Woe to Those Who Are Trapped When the Daily Pattern Is Broken
Mar-06-17 04:05PM  Aurinia Announces Acceptance of Voclosporin Late-Breaking Presentation at the National Kidney Foundation 2017 Spring Clinical Meetings Business Wire +11.43%
Mar-03-17 11:54AM  Market Action Is Boring but Necessary +6.18%
09:30AM  Biotech Industry Rally Grows as Trump Vows to Cut Regulations: Today's Reports on Aurinia Pharmaceuticals and Nektar Therapeutics Accesswire
Mar-02-17 01:15PM  Patient Death Fears Allayed For Aurinia Pharmaceuticals Inc (AUPH), Whats Next? at Insider Monkey +22.10%
01:12PM  Aurinia to Present at Cowen and Company 37th Annual Healthcare Conference Business Wire
12:20PM  Thursdays Top Biopharma Movers
11:39AM  Aurinia Pharma Spikes on Lupus Drug Safety at Investopedia
11:15AM  Shark Bites: Market Taking a Break, but Probably Not for Long
09:32AM  Biotech Premarket Movers: Aurinia, Puma, PTC, Juno
Mar-01-17 04:12PM  Aurinia's lupus drug shows no new safety concerns
04:05PM  Aurinia Pharma Kidney Drug Exits Study Update with Clean Safety Profile
04:05PM  Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints, Achieving Highest Complete Remission Rate of Any Global Lupus Nephritis Study Business Wire
Feb-22-17 08:20AM  Aurinia Pharmaceuticals (AUPH) Shares March Higher, Can It Continue? -7.61%
Feb-14-17 07:00AM  Aurinia Announces Results from Japanese Phase I Ethnic Bridging Study for Voclosporin Business Wire
Feb-10-17 02:44PM  Aurinias New CEO, Richard Glickman, to Present at Leerink Partners 6th Annual Global Healthcare Conference Business Wire
Feb-06-17 05:15PM  Aurinia Announces Appointment of Company Founder, Dr. Richard M. Glickman, as its New Chief Executive Officer Business Wire
Feb-03-17 09:35AM  Can The Uptrend Continue for Aurinia Pharmaceuticals (AUPH)?
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.